FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...
U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first ...
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.
A rather historic U.S. Food and Drug Administration (FDA) proposal aims to make cigarettes and other tobacco products far ...
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
Now it competes with or is similar to, among others: Altria posted better-than-expected third-quarter results as robust vape and nicotine pouch demand offset shrinking market share for the ...
Even if the effort goes ahead under Trump, tobacco companies like Reynolds American and Altria are almost certain ... and said Wednesday that reducing nicotine would help nearly 13 million current ...
In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback